{
  "system_prompt": "You are a buy-side equity PM constructing a long-only portfolio from scored candidates.\nRules:\n- Select exactly 20 stocks from the scored candidates provided.\n- Assign weights between 2% and 10% per stock (0.02 to 0.10).\n- Weights must sum to exactly 100% (1.0).\n- Diversify across sectors and industries (respect sector_cap and industry_cap constraints).\n- Prioritize stocks with higher composite scores, but ensure diversification.\n- Consider sector/industry balance and avoid over-concentration.\n- Output must be strict JSON.",
  "user_prompt": "Portfolio Construction Task:\n\n      Investment Horizon: Today to 2026-05-15 (126 days remaining)\n\n      Constraints:\n      - Select EXACTLY 20 stocks\n      - Weight per stock: 2% to 10% (0.02 to 0.10)\n      - Total weight must sum to EXACTLY 100% (1.0)\n      - Sector cap: 35% (no single sector > 35%)\n      - Industry cap: 20% (no single industry > 20%)\n      - Long-only portfolio (no short positions)\n\n      Scored Candidates (sorted by composite score, showing top 40):\n        GOOGL: score=0.626, sector=Communication Services, sentiment=bullish, price=$325.44, theme=Regulatory Changes Impacting Technology and Finance\n  News: Canaccord Genuity has raised its price target for Alphabet Inc. (GOOGL) from $330 to $390, maintaining a Buy rating, indicating strong confidence in the stock's potential despite some near-term caution. This comes amid a broader trend of tech companies, including GOOGL, focusing on artificial intelligence advancements, which are expected to drive future growth. Additionally, competition in the AI space is intensifying, with companies like Amazon and Nvidia making significant moves to establish leadership. Overall, GOOGL remains a compelling investment option as it navigates the evolving tech landscape.\nMRK: score=0.613, sector=Health Care, sentiment=bullish, price=$110.99\n  News: Merck (MRK) is currently in discussions to acquire Revolution Medicines, a cancer drugmaker valued at over $20 billion, which has positively impacted Revolution's stock price. Wolfe Research has upgraded Merck, highlighting its potential for growth beyond its flagship drug, Keytruda, while Wells Fargo has added the company to its Q1 2026 Tactical Ideas List, citing a catalyst-rich period ahead. Merck's stock recently closed at $110.99, reflecting a 2.2% increase, indicating strong market performance amid these developments.\nV: score=0.577, sector=Financials, sentiment=bullish, price=$352.23, theme=Regulatory Changes Impacting Technology and Finance\n  News: Visa Inc. (NYSE:V) has been highlighted as a strong investment option, with a recent price target set at $330 by Monness Crespi Hardt & Co. The company has seen a share price increase of 7.9% over the past month and a total shareholder return of 13.5% over the past year, indicating positive momentum. Additionally, Visa's collaboration with Deluxe to implement Visa Direct aims to enhance cash flow solutions for businesses, further solidifying its position in the payments sector. Despite a slight decline in stock price to $352.23, analysts maintain a favorable outlook on Visa's valuation and growth potential.\nMA: score=0.572, sector=Financials, sentiment=bullish, price=$580.07\n  News: Mastercard Incorporated (NYSE:MA) continues to receive positive attention from analysts, with Monness Crespi Hardt & Co. maintaining a Hold rating and a price target of $525, while Keefe, Bruyette & Woods has a Buy rating. The average brokerage recommendation for Mastercard is currently equivalent to a Buy, indicating strong market interest. As the payments landscape evolves, particularly with the transition of the Apple Card to JPMorgan, Mastercard's position in the fintech sector remains robust, making it a compelling investment option.\nQCOM: score=0.541, sector=Information Technology, sentiment=bullish, price=$181.87\n  News: Qualcomm (QCOM) recently showcased its advancements in AI and robotics at CES 2026, unveiling the Snapdragon X Plus 2 chip designed for PCs and highlighting its role in powering humanoid robots. The company's collaboration with Visteon on automotive technology was also featured, demonstrating the capabilities of its Snapdragon Cockpit Elite platform. Despite these innovations, QCOM's stock experienced a decline of 1.24%, reflecting broader tech market pressures, as the Nasdaq 100 faced challenges amid rising costs and profitability concerns for some of its constituents.\nPFE: score=0.518, sector=Health Care, sentiment=bullish, price=$25.29, theme=Healthcare Innovation and Biotech Advancements\n  News: Pfizer Inc. (PFE) has recently announced strategic collaborations with Boltz and Cartography Biosciences to leverage AI in drug discovery and enhance its oncology pipeline, reflecting a significant shift towards advanced technology in its R&D processes. Additionally, positive Phase 3 trial results for the combination of PADCEV and Keytruda in bladder cancer treatment further bolster Pfizer's position in the oncology market. These developments indicate a proactive approach to improving pipeline productivity and addressing competitive pressures in the pharmaceutical industry.\nFSLR: score=0.510, sector=Utilities, sentiment=bullish, price=$246.26, theme=Energy Transition and Sustainability\n  News: First Solar (FSLR) has experienced a notable decline of 7.7% following a downgrade from Jefferies, which shifted its rating from Buy to Hold due to concerns over weaker bookings and project cancellations. Despite a strong performance over the past year, with a 28.8% return, the stock has faced a 10.2% decline year-to-date. Analysts remain divided, with some maintaining bullish views, but the recent downgrade raises questions about the stock's valuation and future growth potential in a challenging market environment.\nREGN: score=0.493, sector=Health Care, sentiment=bullish, price=$801.01, theme=Healthcare Innovation and Biotech Advancements\n  News: Regeneron Pharmaceuticals (REGN) has recently experienced a positive shift in market sentiment, highlighted by upgrades from major banks like Bank of America and Citi, which raised their price targets significantly to $860 and $900, respectively. This comes ahead of the company's fourth-quarter earnings report scheduled for January 30, 2026, where analysts expect REGN to continue its history of earnings surprises. Additionally, a decline in short interest suggests reduced bearish sentiment among investors, indicating growing confidence in Regeneron's future prospects and pipeline updates for 2026.\nJPM: score=0.490, sector=Financials, sentiment=bullish, price=$329.79\n  News: JPMorgan Chase & Co. is set to report its Q4 earnings on January 13, 2025, with analysts predicting an increase in earnings per share to $5.01 and revenue growth to $46.25 billion. The bank is also optimistic about easing outflows from cryptocurrency ETFs, indicating potential stabilization in the crypto market. Additionally, JPMorgan is expanding its blockchain initiatives, aiming to enhance its digital currency capabilities. Furthermore, Apple is transitioning its credit card services from Goldman Sachs to JPMorgan, which could impact customer engagement and revenue streams.\nAAPL: score=0.467, sector=Information Technology, sentiment=bullish, price=$259.04, theme=Regulatory Changes Impacting Technology and Finance\n  News: Apple Inc. (AAPL) continues to receive positive investment sentiment, with Bernstein reiterating a Buy rating and setting a price target of $325. The company benefits from its partnership with TSMC, which reported a 20% increase in fourth-quarter revenue, driven by strong demand for AI applications and semiconductor products. This trend is expected to bolster Apple's performance, particularly following the successful launch of the iPhone 17. Additionally, Bank of America Securities also reaffirmed a positive outlook for AAPL, indicating strong confidence in its market position.\nADBE: score=0.461, sector=Information Technology, sentiment=bullish, price=$339.04\n  News: Adobe Inc. (ADBE) has recently garnered attention for its strategic partnership with Runway, enhancing its AI video tools, which positions it favorably in the growing AI market. Despite a challenging year with a 20.5% decline in total shareholder return, analysts suggest that ADBE may be undervalued compared to its SaaS peers, particularly with rising AI-driven annual recurring revenue (ARR) and ongoing buybacks. The stock is attracting renewed investor interest as it navigates a mixed performance landscape, indicating potential for recovery in 2026.\nISRG: score=0.454, sector=Health Care, sentiment=bullish, price=$585.08\n  News: Intuitive Surgical, Inc. (ISRG) recently experienced a slight decline, closing at $585.08, but has seen a significant 32% increase over the past three months, driven by strong demand for its da Vinci robotic systems and new FDA approvals expanding surgical applications. The stock is currently trading just 4% below its all-time high, reflecting positive investor sentiment amid rising procedure volumes and utilization rates. Analysts are closely monitoring the company's valuation as it continues to capitalize on the growing demand for minimally invasive surgical solutions. Overall, ISRG remains a trending stock with strong long-term performance indicators, including a 125.58% total shareholder return over five years.\nJNJ: score=0.454, sector=Health Care, sentiment=bullish, price=$205.75\n  News: Johnson & Johnson (JNJ) has reached a voluntary agreement with the Trump Administration to cut drug prices for Americans, which includes tariff exemptions for its pharmaceutical products. This move is expected to enhance access to medicines and lower costs for millions of patients. Additionally, JNJ is focusing on growth in its Innovative Medicine and MedTech segments to mitigate challenges from the Stelara patent cliff. Recent pipeline updates, including a Phase 2b win for nipocalimab and an FDA submission for the OTTAVA surgical system, indicate positive momentum for the company's future prospects.\nNVDA: score=0.442, sector=Information Technology, sentiment=bullish, price=$185.04, theme=AI Infrastructure Buildout\n  News: Nvidia is actively pursuing partnerships with auto suppliers to advance its self-driving technology, despite challenges in safety and costs. Meanwhile, TSMC, Nvidia's primary chip supplier, reported a 20% revenue increase in Q4, driven by strong demand for AI applications, which bodes well for Nvidia's outlook. Citi has reiterated a Buy rating on Nvidia, setting a price target of $270, reflecting confidence in the company's growth potential in the AI sector. Additionally, Nvidia has appointed a new chief marketing officer from Google, aiming to enhance its market presence amid current stock performance challenges.\nSYK: score=0.437, sector=Health Care, sentiment=bullish, price=$367.21\n  News: Stryker Corporation (SYK) recently received an upgrade from Raymond James to 'Outperform,' citing its strong track record of over 10% organic revenue growth and a favorable position in the medical technology sector. Following this upgrade, SYK shares rose by 4.1%, with a new price target set at $418. Despite these positive developments, some analysts express concerns about ongoing margin pressures and question whether the current valuation is justified given the company's growth rate. Overall, Stryker's consistent performance and market positioning continue to attract investor interest amid mixed market sentiment.\nMSFT: score=0.433, sector=Information Technology, sentiment=bullish, price=$478.11, theme=Regulatory Changes Impacting Technology and Finance\n  News: Microsoft (MSFT) recently announced the acquisition of Osmos, an AI data engineering platform, which is expected to enhance its capabilities in simplifying data workflows. Despite a slight decline in stock price, analysts remain optimistic, with Jefferies maintaining a Buy rating and a price target of $675, citing Microsoft's strong AI strategy as a long-term advantage. The broader market has shown mixed reactions to tech stocks, with investors becoming more selective in AI-related investments. As the company continues to innovate and expand its AI offerings, it is positioned to capitalize on the growing demand for AI technologies.\nCSCO: score=0.433, sector=Information Technology, sentiment=bullish, price=$73.96\n  News: Cisco Systems (CSCO) has recently seen a slight decline in its stock price, closing at $73.96, down 1.02% amid broader market gains. Analysts from TD Cowen indicated that an acquisition of Axonius by Cisco is not imminent, which may impact investor sentiment. Despite a strong historical performance, with a 29.3% increase over the past year, the stock has faced a 3.0% drop in the last week and 5.2% over the past month, prompting discussions about its current valuation and long-term growth potential in the networking and security sectors.\nAMGN: score=0.420, sector=Health Care, sentiment=neutral, price=$330.11, theme=Healthcare Innovation and Biotech Advancements\n  News: Amgen (AMGN) experienced a decline of 3.39%, closing at $330.05 amid a broader market uptick. The company recently secured exclusive global rights from DISCO Pharmaceuticals for cancer therapies, potentially worth up to $618 million, enhancing its oncology portfolio. Additionally, Amgen's acquisition of Dark Blue Therapeutics for $840 million is expected to strengthen its early oncology pipeline. The company is set to present at the J.P. Morgan Healthcare Conference on January 12, 2026, which may provide further insights into its strategic direction.\nVZ: score=0.416, sector=Communication Services, sentiment=bullish, price=$40.57\n  News: Verizon Communications (VZ) saw a slight increase in its stock price, closing at $40.57, amid growing concerns over a potential wireless price war with competitors AT&T and T-Mobile. The company is actively engaging customers through high-profile events like the Super Bowl and FIFA World Cup, showcasing its Industrial IoT capabilities at CES 2026. However, T-Mobile has recently outperformed Verizon and AT&T in key network rankings, raising questions about Verizon's competitive position in the market. Investors should monitor these developments as they may impact Verizon's market share and growth prospects.\nMCD: score=0.379, sector=Consumer Discretionary, sentiment=neutral, price=$308.88\n  News: McDonald's (MCD) is currently in the spotlight due to a high-profile McRib class action lawsuit and new family-oriented promotions, including a Crayola partnership and a Pok\u00e9mon Happy Meal campaign set for 2026. Analysts remain cautiously optimistic, with approximately 45% maintaining a bullish outlook and a median price target of $340, suggesting a potential upside of 13.4%. Despite recent fluctuations, including a slight decline in share price over the past month, the stock has shown steady long-term performance with a 1-year return of 8.49%. Additionally, movements in the options market indicate heightened investor interest, warranting close attention to MCD's stock.\nKO: score=0.379, sector=Consumer Staples, sentiment=bullish, price=$69.37\n  News: Coca-Cola (NYSE: KO) has been added to Wells Fargo's Q1 2026 Tactical Ideas List, highlighting its favorable positioning for the upcoming year. The stock continues to be recognized as a reliable dividend aristocrat, attracting investor attention amid discussions about its long-term payout reliability. CEO James Quincey's recent interview emphasizes the company's commitment to balancing tradition with innovation as it navigates market changes. Overall, KO remains a focal point for investors looking for stable dividend stocks in 2026.\nHD: score=0.374, sector=Consumer Discretionary, sentiment=bullish, price=$359.56, theme=Labor Market Dynamics and Wage Growth\n  News: Home Depot (HD) is gaining attention as a potential beneficiary of a shift in investor sentiment towards cash-rich retailers amid easing Federal Reserve interest rates. Analysts note that high home prices and mortgage costs are prompting homeowners to invest in renovations rather than moving, which could bolster demand for Home Depot's products. The stock recently closed at $349.29, reflecting a 1.51% increase, indicating positive market momentum. Additionally, Jim Cramer has expressed a preference for Home Depot over competitors like Fortune Brands, further highlighting its strong position in the housing market.\nMDT: score=0.372, sector=Health Care, sentiment=bullish, price=$98.69\n  News: Medtronic (MDT) has recently gained attention following an upgrade to 'Outperform' by William Blair, which highlights the positive impact of FDA approvals for its Hugo surgical system and the Symplicity Spyral device. The stock has shown a short-term upward trend, with a 3.03% increase in one day and a 3.78% rise over the past week. Additionally, a study on the MiniMed\u2122 780G system demonstrated its effectiveness in achieving ADA-recommended time-in-range goals, further supporting Medtronic's position in the diabetes management market. Despite a recent share price pullback, MDT has delivered a 25.7% return over the past year, indicating potential value for investors.\nNOW: score=0.368, sector=Information Technology, sentiment=bullish, price=$146.19\n  News: ServiceNow (NOW) has experienced a notable decline in its stock price, closing at $150.90, reflecting an 11.6% drop over the past month and a 28.1% decline year-over-year. Despite this, analysts from Jefferies and Canaccord Genuity have reaffirmed a bullish outlook, with Jefferies naming it a top AI growth stock and Canaccord setting a price target of $224.00. The company is set to announce its fourth-quarter and full-year financial results on January 28, 2026, which could provide further insights into its performance amidst mixed market sentiments. Additionally, Jim Cramer has expressed concerns about its high price-to-earnings multiple in the current market environment.\nMETA: score=0.366, sector=Communication Services, sentiment=bearish, price=$646.06\n  News: Recent reports indicate that Alexandr Wang, Meta's highest-paid employee, is feeling 'suffocated' due to the micromanagement style of CEO Mark Zuckerberg. This dissatisfaction could signal potential challenges in leadership dynamics within the company, which may affect employee morale and productivity. Investors should monitor how this internal strife might influence Meta's operational efficiency and overall corporate culture moving forward.\nCOIN: score=0.366, sector=Financials, sentiment=neutral, price=$245.59, theme=Regulatory Changes Impacting Technology and Finance\n  News: Coinbase (COIN) received an upgrade to 'Buy' from Bank of America, which cited the company's product expansion and favorable valuation as key factors for potential growth in 2026. Despite this positive outlook, COIN's stock experienced a slight decline of 1.71% recently, closing at $250.56. The broader cryptocurrency market is showing signs of recovery, with Bitcoin stabilizing above $91,000 after a tumultuous period, which may positively influence Coinbase's performance. Additionally, the competitive landscape is shifting, as Goldman Sachs upgraded Coinbase while downgrading eToro, highlighting the evolving dynamics in the trading and crypto sectors.\nZTS: score=0.349, sector=Health Care, sentiment=bullish, price=$126.85\n  News: Zoetis Inc. (ZTS) has faced significant share price declines, with a 19.8% drop over the past year and a sell rating from analysts due to slowing growth and lowered guidance. Despite recent outperformance on a strong trading day, concerns about its valuation persist, with an EV/FCF ratio near 25x. Notably, investment strategist Stephanie Link has increased her holdings in Zoetis, indicating potential confidence in the stock amidst its current challenges. The veterinary diagnostics market is expected to grow, which could benefit Zoetis in the long term.\nPG: score=0.347, sector=Consumer Staples, sentiment=bullish, price=$141.53\n  News: Procter & Gamble (PG) has recently faced challenges, including legal scrutiny over some of its products and a decline in demand, leading to a 52-week low in its stock price. Despite reporting revenue and EPS growth in Q1, analysts express concerns about its valuation, prompting Wells Fargo to lower its price target from $170 to $158 while maintaining an Overweight rating. The company is also navigating complex markets and preparing for an earnings call under new CEO Shailesh Jejurikar, which may influence its pricing strategy moving forward. Overall, while PG remains a strong brand with a solid dividend yield, near-term pressures could impact investor sentiment.\nLULU: score=0.347, sector=Consumer Discretionary, sentiment=neutral, price=$212.17\n  News: Lululemon athletica (LULU) is currently navigating a leadership transition as founder Chip Wilson challenges the board by nominating three independent director candidates amid an ongoing CEO search. Despite this internal turmoil, the company has reported a 10.95% return over the past 30 days and a 21.74% return over the last 90 days, although it has experienced a significant 46.67% decline in total shareholder return over the past year. Additionally, trade policy risks are prompting LULU to consider diversifying its supply chain to mitigate rising costs. Overall, the retail sector outlook for 2026 appears positive, which may benefit LULU as consumer conditions improve.\nNFLX: score=0.327, sector=Communication Services, sentiment=neutral, price=$90.53\n  News: Netflix (NFLX) has recently faced a downgrade from CFRA, reducing its price target from $130 to $100, primarily due to its pending acquisition of Warner Bros Discovery, which has contributed to a nearly 13% stock drop in December. Despite this, Netflix is working to improve its relationship with AMC Theaters, which could enhance its market position. The company also completed a 10-for-1 stock split in November, attracting mixed investor sentiment as it navigates these challenges. Overall, the market remains cautious as Netflix's strategic moves unfold amid competitive pressures.\nPEP: score=0.314, sector=Consumer Staples, sentiment=bullish, price=$139.37\n  News: PepsiCo (PEP) has announced a significant multi-year partnership with Siemens and NVIDIA to implement AI and digital twin technology across its operations, aiming to enhance efficiency and reduce capital expenditures. Despite this strategic move, PEP's stock has experienced a decline, with a 4.54% drop over the past week and a modest 2.77% total return over the past year. This collaboration positions PepsiCo as a leader in adopting advanced industrial technologies within the consumer packaged goods sector, potentially impacting its operational performance and investor sentiment moving forward.\nLOW: score=0.306, sector=Consumer Discretionary, sentiment=bullish, price=$256.21\n  News: Lowe's Companies (LOW) has recently received an upgrade from Barclays to overweight, reflecting optimism about the home improvement retailer's potential benefits from an improving housing market and pent-up demand. The stock has shown modest momentum with a 90-day return of 5.31% and a 1-year total shareholder return of 2.10%. Additionally, Lowe's is recognized as a reliable dividend payer, included among the best dividend growth stocks for 2026, with a payout ratio of approximately 40%. Overall, the recent analyst upgrades and stable demand position Lowe's favorably in the current market environment.\nXOM: score=0.303, sector=Energy, sentiment=bullish, price=$122.91\n  News: ExxonMobil is actively participating in discussions with the White House and other major oil companies regarding potential investments to revitalize Venezuela's struggling energy sector. The company, which previously exited Venezuela due to nationalization policies, is now considering re-entering the market amidst rising oil prices and increased demand. Analysts are optimistic about XOM stock, suggesting it remains a strong buy as energy stocks gain traction in the current market environment. However, challenges remain due to Venezuela's severely degraded oil infrastructure and production capabilities.\nUNH: score=0.299, sector=Health Care, sentiment=bullish, price=$346.85\n  News: UnitedHealth Group (NYSE:UNH) has recently seen positive analyst sentiment, with Bernstein raising its price target to $444 and Barclays increasing its target to $391, both maintaining favorable ratings. The stock has outperformed market gains, closing at $346.85, and is recognized as a top investment choice for 2026 amid expectations of margin recovery in managed care. Analysts are optimistic about UNH's revenue prospects and operational recovery, suggesting a potential turnaround following a challenging 2025. Overall, renewed confidence from analysts highlights UNH's strong position in the insurance market.\nGILD: score=0.279, sector=Health Care, sentiment=bullish, price=$120.67\n  News: Gilead Sciences (GILD) has experienced mixed stock performance recently, with a slight decline of 2.71% in the latest trading session, despite a 37.65% total shareholder return over the past year. The company is actively involved in collaborations, including a new partnership with OncoNano Medicine to explore drug delivery technologies. Additionally, Gilead is part of the growing TIGIT inhibitors market, which is expected to expand significantly by 2030, indicating potential future growth opportunities. Overall, Gilead's stock has shown a flat year-to-date performance, aligning closely with broader market trends.\nHON: score=0.262, sector=Industrials, sentiment=neutral, price=$205.24, theme=Geopolitical Risk and Supply Chain Resilience\n  News: Honeywell International Inc. (NASDAQ:HON) has seen its price target lowered by Mizuho from $250 to $240, reflecting concerns over an uneven industry backdrop despite maintaining an Outperform rating. The company's aerospace segment is experiencing strong growth driven by increased aftermarket demand and defense spending, which may help offset challenges in manufacturing and supply chain. Additionally, Honeywell is highlighted as a key player in the diversified operations sector, alongside 3M, as they navigate current market headwinds.\nDHR: score=0.254, sector=Health Care, sentiment=bullish, price=$235.0\n  News: Danaher Corporation (DHR) is poised for recovery as it navigates post-COVID challenges, with finalized tariff rules and depleted inventories. The company is a leader in the microtome market, which is expected to grow due to increased demand for disease diagnosis and drug discovery. Analysts are cautiously optimistic ahead of Danaher's upcoming fourth-quarter earnings report, with expectations for stable bottom-line performance year-over-year. Despite recent share price momentum, the stock has shown mixed performance over the past year, prompting discussions about its valuation and growth prospects.\nWMT: score=0.251, sector=Consumer Staples, sentiment=bullish, price=$113.07, theme=Labor Market Dynamics and Wage Growth\n  News: Walmart (WMT) is making significant strides in the digital health sector with the launch of its Better Care Services platform, which connects customers to various healthcare providers and offers wellness products at reduced prices. The company has also welcomed tech leader Shishir Mehrotra to its board, enhancing its focus on technology and health initiatives. Analysts are optimistic about Walmart's prospects, with Mizuho raising its price target to $125 and highlighting it as one of the best Dow stocks for 2026. Additionally, Walmart's strong performance is reflected in its recent share price growth, with a 90-day return of 10.76% and a one-year total shareholder return of 23.96%.\nAMZN: score=0.250, sector=Consumer Discretionary, sentiment=bullish, price=$246.29, theme=Labor Market Dynamics and Wage Growth\n  News: Amazon (AMZN) has recently gained approximately 6% in value, outperforming the S&P 500, which may indicate positive momentum as the company positions itself as a leader in artificial intelligence. Analysts have noted that while Amazon's modeled fair value remains relatively stable, discussions around AI infrastructure and advertising growth are countered by concerns over capital spending and cloud economics. Jim Cramer has expressed that Amazon's previous underperformance was unwarranted, suggesting a potential for recovery. Overall, the stock's recent performance and strategic focus on AI could be significant for investors looking ahead to 2026.\nBIIB: score=0.248, sector=Health Care, sentiment=neutral, price=$186.0\n  News: Biogen (BIIB) and Eisai have received acceptance from Chinese regulators for a Biologics License Application for a subcutaneous, at-home version of their Alzheimer's drug LEQEMBI, which could enhance patient access and alleviate healthcare system pressures in China. This development comes as Biogen's stock has shown a 15.67% return over the past 90 days, contrasting with a flat year-to-date performance. Additionally, mixed analyst opinions are emerging regarding Biogen's future earnings potential, particularly in light of new data on its ALS therapy QALSODY and its recent removal from the Nasdaq-100 index.\n\n      Instructions:\n      1. Select the best 20 stocks considering:\n         - Composite score (higher is better)\n         - Sector diversification (aim for 3-6 sectors, none > 35%)\n         - Industry diversification (none > 20%)\n         - Sentiment alignment (prefer bullish/neutral over bearish)\n         - Theme exposure (balance themed and non-themed stocks)\n\n      2. Assign weights:\n         - Higher scores can get higher weights (up to 10%)\n         - Lower scores should get lower weights (minimum 2%)\n         - Ensure weights sum to exactly 1.0 (100%)\n\n      3. Validate:\n         - Exactly 20 holdings\n         - Each weight between 0.02 and 0.1\n         - Total weight = 1.0\n         - No sector exceeds 35%\n         - No industry exceeds 20%\n\n      Output JSON strictly as:\n      {\n        \"holdings\": [\n          {\n            \"ticker\": \"AAPL\",\n            \"weight\": 0.08,\n            \"sector\": \"Information Technology\",\n            \"theme\": null,\n            \"rationale\": \"High composite score (0.75), strong sentiment, sector leader\",\n            \"composite_score\": 0.75\n          },\n          ... exactly 20 holdings ...\n        ]\n      }",
  "llm_response": {
    "holdings": [
      {
        "ticker": "GOOGL",
        "weight": 0.1,
        "sector": "Communication Services",
        "theme": "Regulatory Changes Impacting Technology and Finance",
        "rationale": "Highest composite score (0.626), strong bullish sentiment, leading tech player.",
        "composite_score": 0.626
      },
      {
        "ticker": "MRK",
        "weight": 0.09,
        "sector": "Health Care",
        "theme": null,
        "rationale": "Strong growth potential with recent acquisition discussions, high score (0.613).",
        "composite_score": 0.613
      },
      {
        "ticker": "V",
        "weight": 0.08,
        "sector": "Financials",
        "theme": "Regulatory Changes Impacting Technology and Finance",
        "rationale": "Solid performance and bullish sentiment, high score (0.577).",
        "composite_score": 0.577
      },
      {
        "ticker": "MA",
        "weight": 0.08,
        "sector": "Financials",
        "theme": null,
        "rationale": "Strong market interest and growth potential, score (0.572).",
        "composite_score": 0.572
      },
      {
        "ticker": "QCOM",
        "weight": 0.07,
        "sector": "Information Technology",
        "theme": null,
        "rationale": "Innovative advancements in AI, solid score (0.541).",
        "composite_score": 0.541
      },
      {
        "ticker": "PFE",
        "weight": 0.07,
        "sector": "Health Care",
        "theme": "Healthcare Innovation and Biotech Advancements",
        "rationale": "Strategic collaborations and strong pipeline, score (0.518).",
        "composite_score": 0.518
      },
      {
        "ticker": "FSLR",
        "weight": 0.06,
        "sector": "Utilities",
        "theme": "Energy Transition and Sustainability",
        "rationale": "Despite recent challenges, strong long-term performance, score (0.510).",
        "composite_score": 0.51
      },
      {
        "ticker": "REGN",
        "weight": 0.06,
        "sector": "Health Care",
        "theme": "Healthcare Innovation and Biotech Advancements",
        "rationale": "Positive market sentiment and strong pipeline, score (0.493).",
        "composite_score": 0.493
      },
      {
        "ticker": "AAPL",
        "weight": 0.06,
        "sector": "Information Technology",
        "theme": "Regulatory Changes Impacting Technology and Finance",
        "rationale": "Strong market position and positive outlook, score (0.467).",
        "composite_score": 0.467
      },
      {
        "ticker": "JPM",
        "weight": 0.05,
        "sector": "Financials",
        "theme": null,
        "rationale": "Positive earnings outlook and growth potential, score (0.490).",
        "composite_score": 0.49
      },
      {
        "ticker": "ISRG",
        "weight": 0.05,
        "sector": "Health Care",
        "theme": null,
        "rationale": "Strong demand for surgical systems, score (0.454).",
        "composite_score": 0.454
      },
      {
        "ticker": "JNJ",
        "weight": 0.05,
        "sector": "Health Care",
        "theme": null,
        "rationale": "Positive pipeline updates and market position, score (0.454).",
        "composite_score": 0.454
      },
      {
        "ticker": "MSFT",
        "weight": 0.05,
        "sector": "Information Technology",
        "theme": "Regulatory Changes Impacting Technology and Finance",
        "rationale": "Strong AI strategy and market position, score (0.433).",
        "composite_score": 0.433
      },
      {
        "ticker": "KO",
        "weight": 0.03,
        "sector": "Consumer Staples",
        "theme": null,
        "rationale": "Stable dividend stock with strong market positioning, score (0.379).",
        "composite_score": 0.379
      },
      {
        "ticker": "HD",
        "weight": 0.03,
        "sector": "Consumer Discretionary",
        "theme": "Labor Market Dynamics and Wage Growth",
        "rationale": "Benefiting from home renovation trends, score (0.374).",
        "composite_score": 0.374
      },
      {
        "ticker": "NFLX",
        "weight": 0.02,
        "sector": "Communication Services",
        "theme": null,
        "rationale": "Navigating challenges but potential for recovery, score (0.327).",
        "composite_score": 0.327
      },
      {
        "ticker": "AMZN",
        "weight": 0.02,
        "sector": "Consumer Discretionary",
        "theme": "Labor Market Dynamics and Wage Growth",
        "rationale": "Positive momentum in AI and market position, score (0.250).",
        "composite_score": 0.25
      }
    ]
  },
  "model": "gpt-4o-mini",
  "timestamp": "2026-01-09T06:27:33.034950"
}